Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.81 USD | +0.08% | +3.31% | -27.87% |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 88.72B | 97.45B | 111B | 97.25B | 106B | |||||
Other Revenues, Total | 4.27B | 4.41B | 5.8B | 5.9B | 7.24B | |||||
Total Revenues | 92.99B | 102B | 117B | 103B | 113B | |||||
Cost of Goods Sold, Total | 72.31B | 80.57B | 93.95B | 81.54B | 87.14B | |||||
Gross Profit | 20.68B | 21.29B | 23.11B | 21.62B | 25.72B | |||||
Selling General & Admin Expenses, Total | 14.08B | 14.86B | 16.87B | 14.07B | 15.49B | |||||
R&D Expenses | 1.57B | 1.22B | 1.52B | 1.61B | 1.77B | |||||
Other Operating Expenses | -563M | -574M | -755M | -557M | -638M | |||||
Other Operating Expenses, Total | 15.08B | 15.51B | 17.63B | 15.12B | 16.62B | |||||
Operating Income | 5.6B | 5.77B | 5.47B | 6.5B | 9.1B | |||||
Interest Expense, Total | -86M | -67.36M | -14.46M | -24.26M | -22.93M | |||||
Interest And Investment Income | 217M | 449M | 671M | 764M | 780M | |||||
Net Interest Expenses | 131M | 382M | 657M | 740M | 757M | |||||
Income (Loss) On Equity Invest. | 27.18M | 30.02M | 42.3M | -6.56M | 80.3M | |||||
Currency Exchange Gains (Loss) | -935K | -160M | -37.05M | 688M | 163M | |||||
Other Non Operating Income (Expenses) | - | - | - | - | - | |||||
EBT, Excl. Unusual Items | 5.76B | 6.03B | 6.14B | 7.92B | 10.1B | |||||
Restructuring Charges | -154M | - | - | - | - | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Impairment of Goodwill | -278M | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | 39.34M | 938M | -329M | 452M | -37.16M | |||||
Gain (Loss) On Sale Of Assets | -14.4M | -7.75M | -5.69M | -34.78M | -5.26M | |||||
Asset Writedown | -476M | -47.02M | -61.92M | -239M | -156M | |||||
Insurance Settlements | 96.39M | 141M | 175M | 203M | 169M | |||||
Other Unusual Items | - | - | - | -232M | - | |||||
EBT, Incl. Unusual Items | 4.97B | 7.05B | 5.92B | 8.07B | 10.07B | |||||
Income Tax Expense | 984M | 1.13B | 1.22B | 1.76B | 1.87B | |||||
Earnings From Continuing Operations | 3.99B | 5.92B | 4.69B | 6.31B | 8.2B | |||||
Net Income to Company | 3.99B | 5.92B | 4.69B | 6.31B | 8.2B | |||||
Minority Interest | 30.4M | -12.4M | -11.8M | -13.02M | -84.68M | |||||
Net Income - (IS) | 4.02B | 5.91B | 4.68B | 6.3B | 8.12B | |||||
Net Income to Common Incl Extra Items | 4.02B | 5.91B | 4.68B | 6.3B | 8.12B | |||||
Net Income to Common Excl. Extra Items | 4.02B | 5.91B | 4.68B | 6.3B | 8.12B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 6.02 | 8.75 | 6.88 | 9.9 | 14.66 | |||||
Basic EPS - Continuing Operations | 6.02 | 8.75 | 6.88 | 9.9 | 14.66 | |||||
Basic Weighted Average Shares Outstanding | 668M | 675M | 681M | 636M | 553M | |||||
Net EPS - Diluted | 5.92 | 8.56 | 6.75 | 9.83 | 14.42 | |||||
Diluted EPS - Continuing Operations | 5.92 | 8.56 | 6.75 | 9.83 | 14.42 | |||||
Diluted Weighted Average Shares Outstanding | 680M | 690M | 694M | 641M | 563M | |||||
Normalized Basic EPS | 5.43 | 5.56 | 5.62 | 7.76 | 11.25 | |||||
Normalized Diluted EPS | 5.33 | 5.44 | 5.51 | 7.71 | 11.06 | |||||
Dividend Per Share | - | - | - | - | 3.05 | |||||
American Depositary Receipts Ratio (ADR) | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |||||
Supplemental Items | ||||||||||
EBITDA | 6.45B | 6.78B | 6.58B | 7.74B | 10.4B | |||||
EBITA | 5.62B | 5.81B | 5.49B | 6.5B | 9.1B | |||||
EBIT | 5.6B | 5.77B | 5.47B | 6.5B | 9.1B | |||||
EBITDAR | 7.3B | 7.52B | 7.25B | 8.25B | 10.88B | |||||
Total Revenues (As Reported) | 92.99B | 102B | 117B | 103B | 113B | |||||
Effective Tax Rate - (Ratio) | 19.79 | 16.03 | 20.67 | 21.79 | 18.54 | |||||
Current Domestic Taxes | 974M | 1.26B | 1.37B | - | - | |||||
Total Current Taxes | 974M | 1.26B | 1.37B | 1.71B | 1.75B | |||||
Deferred Domestic Taxes | 9.35M | -126M | -152M | - | - | |||||
Total Deferred Taxes | 9.35M | -126M | -152M | 49.51M | 116M | |||||
Normalized Net Income | 3.63B | 3.75B | 3.82B | 4.94B | 6.23B | |||||
Interest Capitalized | 1.63M | - | - | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 2.23B | 3.08B | 3.28B | 1.75B | 3.28B | |||||
Marketing Expenses | 1.05B | 1.19B | 1.78B | 1.07B | -37.78M | |||||
Selling and Marketing Expenses | 3.32B | 4.28B | 5.09B | 2.83B | 3.24B | |||||
General and Administrative Expenses | 3.43B | 3.7B | 4.13B | 3.99B | 3.99B | |||||
Research And Development Expense From Footnotes | 1.57B | 1.22B | 1.52B | 1.61B | 1.77B | |||||
Net Rental Expense, Total | 851M | 743M | 662M | 516M | 479M | |||||
Imputed Operating Lease Interest Expense | 125M | 143M | 25.3M | 28.04M | 28.42M | |||||
Imputed Operating Lease Depreciation | 725M | 600M | 636M | 488M | 450M | |||||
Stock-Based Comp., R&D Exp. (Total) | 180M | 152M | 253M | 243M | 330M | |||||
Stock-Based Comp., S&M Exp. (Total) | 35.04M | 16.53M | 26.83M | 14.63M | 33.38M | |||||
Stock-Based Comp., G&A Exp. (Total) | 360M | 682M | 641M | 876M | 1.07B | |||||
Stock-Based Comp., SG&A Exp. (Total) | 113M | 100M | 88.98M | 74.06M | 77.93M | |||||
Total Stock-Based Compensation | 688M | 951M | 1.01B | 1.21B | 1.51B |